If it’s any consolation, this ordeal will make you the prohibitive favorite next time you’re in a “Who Has the Best Bad Boss ...
In December 2024, the National Comprehensive Cancer Network® (NCCN) added AUCATZYL (obecabtagene autoleucel) to its Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for the treatment of ...
Advancement of oral, brain-penetrant NLRP3 inhibitor BGE-102, with initial clinical data expected 2H25Progression of preclinical next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback